» Articles » PMID: 38462620

Tryptophan Metabolism in Digestive System Tumors: Unraveling the Pathways and Implications

Overview
Publisher Biomed Central
Date 2024 Mar 11
PMID 38462620
Authors
Affiliations
Soon will be listed here.
Abstract

Tryptophan (Trp) metabolism plays a crucial role in influencing the development of digestive system tumors. Dysregulation of Trp and its metabolites has been identified in various digestive system cancers, including esophageal, gastric, liver, colorectal, and pancreatic cancers. Aberrantly expressed Trp metabolites are associated with diverse clinical features in digestive system tumors. Moreover, the levels of these metabolites can serve as prognostic indicators and predictors of recurrence risk in patients with digestive system tumors. Trp metabolites exert their influence on tumor growth and metastasis through multiple mechanisms, including immune evasion, angiogenesis promotion, and drug resistance enhancement. Suppressing the expression of key enzymes in Trp metabolism can reduce the accumulation of these metabolites, effectively impacting their role in the promotion of tumor progression and metastasis. Strategies targeting Trp metabolism through specific enzyme inhibitors or tailored drugs exhibit considerable promise in enhancing therapeutic outcomes for digestive system tumors. In addition, integrating these approaches with immunotherapy holds the potential to further enhance treatment efficacy.

Citing Articles

Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer.

Yan J, Chen D, Ye Z, Zhu X, Li X, Jiao H Mol Cancer. 2024; 23(1):241.

PMID: 39472902 PMC: 11523861. DOI: 10.1186/s12943-024-02164-y.


Tryptophan Metabolism Disorder-Triggered Diseases, Mechanisms, and Therapeutic Strategies: A Scientometric Review.

Chen X, Xu D, Yu J, Song X, Li X, Cui Y Nutrients. 2024; 16(19).

PMID: 39408347 PMC: 11478743. DOI: 10.3390/nu16193380.


pyRforest: a comprehensive R package for genomic data analysis featuring scikit-learn Random Forests in R.

Kolisnik T, Keshavarz-Rahaghi F, Purcell R, Smith A, Silander O Brief Funct Genomics. 2024; 24.

PMID: 39373492 PMC: 11735746. DOI: 10.1093/bfgp/elae038.


Revealing the association between East Asian oral microbiome and colorectal cancer through Mendelian randomization and multi-omics analysis.

Gu Y, Jiang L, Shui M, Luo H, Zhou X, Zhang S Front Cell Infect Microbiol. 2024; 14:1452392.

PMID: 39355266 PMC: 11443854. DOI: 10.3389/fcimb.2024.1452392.


Tryptophan As a New Member of RNA-Induced Silencing Complexes Prevents Colon Cancer Liver Metastasis.

Xu F, Ren Y, Teng Y, Mu J, Tang J, Sundaram K Adv Sci (Weinh). 2024; 11(31):e2307937.

PMID: 39031551 PMC: 11336974. DOI: 10.1002/advs.202307937.


References
1.
Li L, Wang T, Li S, Chen Z, Wu J, Cao W . TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway. Front Oncol. 2021; 10:562823. PMC: 7851084. DOI: 10.3389/fonc.2020.562823. View

2.
Li Z, Zhang H . Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2015; 73(2):377-92. PMC: 11108301. DOI: 10.1007/s00018-015-2070-4. View

3.
Biswas S . Metabolic Reprogramming of Immune Cells in Cancer Progression. Immunity. 2015; 43(3):435-49. DOI: 10.1016/j.immuni.2015.09.001. View

4.
Wang L, Tang W, Yang S, He P, Wang J, Gaedcke J . NO /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer. Int J Cancer. 2019; 146(11):3160-3169. PMC: 8189162. DOI: 10.1002/ijc.32733. View

5.
Walczak K, Dabrowski W, Langner E, Zgrajka W, Pilat J, Kocki T . Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand J Gastroenterol. 2011; 46(7-8):903-12. DOI: 10.3109/00365521.2011.579159. View